Literature DB >> 19665815

Perspective on the risk to infants in the Netherlands associated with Cronobacter spp. occurring in powdered infant formula.

M W Reij1, I Jongenburger, E Gkogka, L G M Gorris, M H Zwietering.   

Abstract

Cronobacter spp. has been responsible for severe infections in infants. Relative risks associated with this organism in powdered infant formula (PIF) have been described in several studies. To set priorities and decide on risk management options, it is important for risk managers to have a quantitative perspective on the absolute level of risk of this pathogen within the totality of the burden of illnesses in the population. This study set-out to establish such a perspective for The Netherlands. It addresses the impact of heterogeneity in the distribution of the micro-organism in PIF on risk levels. Based on the assumptions in this study, 60% of formula-fed infants are estimated not to be exposed to Cronobacter spp. during their neonatal period. The mean exposure was calculated to be about 1cfu per infant over the total neonatal period. Even after thorough mixing, artificially contaminated powder shows counts which are more variable than expected from a normal, homogeneous distribution. Therefore, mean exposure levels may not represent a good basis for calculating risks. The burden of disease of Cronobacter infections to the Dutch population was estimated to be 19-24 Disability Adjusted Life Years (DALYs) per year, of which 95% are due to meningitis. As compared to other illnesses Cronobacter infections represent 0.5-2.4% of the total estimated burden of foodborne infections and intoxications. The organism is estimated to be responsible for 0.5-0.7% of the meningitis burden to the entire population of The Netherlands.

Entities:  

Mesh:

Year:  2009        PMID: 19665815     DOI: 10.1016/j.ijfoodmicro.2009.07.011

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  7 in total

1.  Incidence of Cronobacter spp. infections, United States, 2003-2009.

Authors:  Mary E Patrick; Barbara E Mahon; Sharon A Greene; Joshua Rounds; Alicia Cronquist; Katie Wymore; Effie Boothe; Sarah Lathrop; Amanda Palmer; Anna Bowen
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

2.  Time for the 70°C water precautionary option in the home dilution of powdered infant formula.

Authors:  Marco Silano; Paola Paganin; Riccardo Davanzo
Journal:  Ital J Pediatr       Date:  2016-02-19       Impact factor: 2.638

3.  Invasive Cronobacter species infection in infants and children admitted to a rural Kenyan hospital with a high prevalence of malnutrition.

Authors:  Joe D Piper; Salim Mwarumba; Moses Ngari; Benedict Mvera; Susan Morpeth; James A Berkley
Journal:  Paediatr Int Child Health       Date:  2018-03-13       Impact factor: 1.990

Review 4.  Burden of foodborne diseases: think global, act local.

Authors:  Sara M Pires; Binyam N Desta; Lapo Mughini-Gras; Blandina T Mmbaga; Olanrewaju E Fayemi; Elsa M Salvador; Tesfaye Gobena; Shannon E Majowicz; Tine Hald; Peter S Hoejskov; Yuki Minato; Brecht Devleesschauwer
Journal:  Curr Opin Food Sci       Date:  2021-06       Impact factor: 6.031

5.  Investigation on the Factors Affecting Cronobacter sakazakii Contamination Levels in Reconstituted Powdered Infant Formula.

Authors:  Julio Parra-Flores; Alejandra Rodriguez; Francisca Riffo; Sofía M Arvizu-Medrano; E Verónica Arias-Rios; Juan Aguirre
Journal:  Front Pediatr       Date:  2015-08-24       Impact factor: 3.418

6.  Variability in Cell Response of Cronobacter sakazakii after Mild-Heat Treatments and Its Impact on Food Safety.

Authors:  Julio Parra-Flores; Vijay Juneja; Gonzalo Garcia de Fernando; Juan Aguirre
Journal:  Front Microbiol       Date:  2016-04-19       Impact factor: 5.640

7.  Cronobacter sakazakii and Microbiological Parameters in Dairy Formulas Associated With a Food Alert in Chile.

Authors:  Julio Parra-Flores; Fabiola Cerda-Leal; Alejandra Contreras; Nicole Valenzuela-Riffo; Alejandra Rodríguez; Juan Aguirre
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.